Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing the single result
Showing the single result
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Methodological issues: Interest rate and wage growth forecasting
1 × $25.00 Determination of tax adjusted lost income awards
1 × $25.00 Loss of Chance Rules and the Valuation of Loss of Chance Damages
1 × $25.00 Subtotal: $75.00